Literature DB >> 15723810

Spatial separation of HLA-DM/HLA-DR interactions within MIIC and phagosome-induced immune escape.

Wilbert Zwart1, Alexander Griekspoor, Coenraad Kuijl, Marije Marsman, Jacco van Rheenen, Hans Janssen, Jero Calafat, Marieke van Ham, Lennert Janssen, Marcel van Lith, Kees Jalink, Jacques Neefjes.   

Abstract

Major Histocompatibility Complex (MHC) class II molecules, including Human Leukocyte Antigen (HLA)-DR, present peptide fragments from proteins degraded in the endocytic pathway. HLA-DR is targeted to late-endocytic structures named MHC class II-containing Compartments (MIIC), where it interacts with HLA-DM. This chaperone stabilizes HLA-DR during peptide exchange and is critical for successful peptide loading. To follow this process in living cells, we have generated cells containing HLA-DR3/Cyan Fluorescent Protein (CFP), HLA-DM/Yellow Fluorescent Protein (YFP), and invariant chain. HLA-DR/DM interactions were observed by Fluorescence Resonance Energy Transfer (FRET). These interactions were pH insensitive, yet occurred only in internal structures and not at the limiting membrane of MIIC. In a cellular model of infection, phagosomes formed a limiting membrane surrounding internalized Salmonella. HLA-DR and HLA-DM did not interact in Salmonella-induced vacuoles, and HLA-DR was not loaded with antigens. The absence of HLA-DR/DM interactions at the limiting membrane prevents local loading of MHC class II molecules in phagosomes. This may allow these bacteria to successfully evade the immune system.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15723810     DOI: 10.1016/j.immuni.2005.01.006

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  56 in total

Review 1.  Towards a systems understanding of MHC class I and MHC class II antigen presentation.

Authors:  Jacques Neefjes; Marlieke L M Jongsma; Petra Paul; Oddmund Bakke
Journal:  Nat Rev Immunol       Date:  2011-11-11       Impact factor: 53.106

2.  Visualization of Protein Interactions in Living Cells.

Authors:  Tomasz Zal
Journal:  Self Nonself       Date:  2011-04-01

3.  HLA-DP, HLA-DQ, and HLA-DR have different requirements for invariant chain and HLA-DM.

Authors:  Marcel van Lith; Rosanna M McEwen-Smith; Adam M Benham
Journal:  J Biol Chem       Date:  2010-10-19       Impact factor: 5.157

4.  Expression of Beclin1 in the colonic mucosa tissues of patients with ulcerative colitis.

Authors:  Xiaoqian Hao; Bin Yang; Xingshan Liu; Huixiang Yang; Xishuang Liu
Journal:  Int J Clin Exp Med       Date:  2015-11-15

Review 5.  Autophagy in innate and adaptive immunity against intracellular pathogens.

Authors:  Dorothee Schmid; Jörn Dengjel; Oliver Schoor; Stefan Stevanovic; Christian Münz
Journal:  J Mol Med (Berl)       Date:  2006-01-28       Impact factor: 4.599

6.  Antigen-loading compartments for major histocompatibility complex class II molecules continuously receive input from autophagosomes.

Authors:  Dorothee Schmid; Marc Pypaert; Christian Münz
Journal:  Immunity       Date:  2006-12-21       Impact factor: 31.745

Review 7.  MHC class II molecules on the move for successful antigen presentation.

Authors:  Nuno Rocha; Jacques Neefjes
Journal:  EMBO J       Date:  2007-11-29       Impact factor: 11.598

8.  A lumenal domain-dependent pathway for sorting to intralumenal vesicles of multivesicular endosomes involved in organelle morphogenesis.

Authors:  Alexander C Theos; Steven T Truschel; Daniele Tenza; Ilse Hurbain; Dawn C Harper; Joanne F Berson; Penelope C Thomas; Graça Raposo; Michael S Marks
Journal:  Dev Cell       Date:  2006-03       Impact factor: 12.270

Review 9.  HLA-DM and HLA-DO, key regulators of MHC-II processing and presentation.

Authors:  Elizabeth D Mellins; Lawrence J Stern
Journal:  Curr Opin Immunol       Date:  2013-12-08       Impact factor: 7.486

10.  The MHC class II cofactor HLA-DM interacts with Ig in B cells.

Authors:  Henriette Macmillan; Michael J Strohman; Sashi Ayyangar; Wei Jiang; Narendiran Rajasekaran; Armin Spura; Ann J Hessell; Anne-Marie Madec; Elizabeth D Mellins
Journal:  J Immunol       Date:  2014-08-06       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.